Preventing rotavirus gastroenteritis: Do you have the facts?
| Autor: | Carl D. Kirkwood, Geoffrey P. Davidson, Elizabeth J Elliott, Rodney Pearce |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Rotavirus
Pediatrics medicine.medical_specialty Immunization Programs business.industry Australia Rotavirus Vaccines Infant Severe disease Disease Rotavirus gastroenteritis medicine.disease_cause Rotavirus Infections Gastroenteritis Rotavirus infection Vaccination Child Preschool Pediatrics Perinatology and Child Health Hospital admission medicine Humans Adverse effect business Randomized Controlled Trials as Topic |
| Zdroj: | Journal of Paediatrics and Child Health. 43:564-567 |
| ISSN: | 1440-1754 1034-4810 |
| DOI: | 10.1111/j.1440-1754.2007.01163.x |
| Popis: | From 1 July 2007 two new rotavirus vaccines licensed for use in Australia (RotaTeq CSL Biotherapies/Merck and Rotarix Glaxo Smith Kline) will be funded for the National Immunisation Program. The vaccines differ with respect to their composition and the timing and mode of administration. Both have been evaluated in huge randomised trials and shown to be highly effective in preventing rotavirus gastroenteritis, including severe disease requiring hospital admission. Neither has been associated with an increased rate of intussusception; however, surveillance for adverse effects following vaccination will be important. As rotavirus infection is ubiquitous in young children, funding of this vaccine will significantly decrease the enormous morbidity and costs associated with this disease in our community. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text